Woodline Partners »

Cg Oncology shares owned by Woodline Partners

Quarter-by-quarter ownership of Cg Oncology (CGON) shares owned by Woodline Partners from 13F filings

Historical chart of Woodline Partners investment in Cg Oncology

Tip: Access up to 7 years of quarterly data

All positions including Cg Oncology held by Woodline Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cg Oncology by Woodline Partners

Quarter filed Position value Share count Share price at filing
2024-06-30 $17M 525k 31.57
2024-03-31 $23M 525k 43.90

More positions owned by Woodline Partners

Eli Lilly & Co. (LLY)
Regeneron Pharmaceuticals (REGN)
Encana Corporation (OVV)
Te Connectivity SHS (TEL)
Abbvie (ABBV)
Revolution Medicines (RVMD)
Chord Energy Corporation Com New (CHRD)
Meta Platforms Cl A (META)
Marsh & McLennan Companies (MMC)
Permian Resources Corp Class A Com (PR)
Quest Diagnostics Incorporated (DGX)
Civitas Resources Com New (CIVI)
Electronic Arts (EA)
Progressive Corporation (PGR)
Zimmer Holdings (ZBH)

View all positions for Woodline Partners

Top funds holding Cg Oncology

Decheng Capital
TCG Crossover Management
Braidwell
BVF
Vanguard Group
BlackRock
Henderson Group
RA Capital Management
Avidity Partners Management
Franklin Resources
Alliancebernstein
State Street Corporation
Cormorant Asset Management
ABG-WTT Global Life Science Capital Partners GP
Frazier Life Sciences Management

View all funds holding Cg Oncology